[MELANODERMA IN THE COURSE OF TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH MYLERAN].
D002066:Busulfan; D004358:Drug Therapy; D006801:Humans; D007938:Leukemia; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D007951:Leukemia, Myeloid; D010859:Pigmentation Disorders; D014116:Toxicology
D002066:Busulfan
BUSULFAN; DRUG THERAPY; LEUKEMIA, MYELOCYTIC; PIGMENTATION DISORDERS; TOXICOLOGIC REPORT
MELANODERMIE AU COURS DU TRAITEMENT D'UNE LEUCOSE MYELOIDE CHRONIQUE PAR LE MYLERAN.